Investigation of the LRRK2 G2385R Mutation (joint with Chinese National Human Genome Center Beijing (SinoGenoMax), Xuanwu Hospital of Capital Medical University)

StatusFinished
Effective start/end date1/08/1831/07/19

Funding

  • (15136): £66,921.80